External News
‘Lost time and momentum’
Press Release
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
Read More
News
Geekwire: Researchers discover new avenue for fighting COVID-19, Ebola and other viral diseases
Read More
Press Release
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
Read More
External News
New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI
Read more ➡
News
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology
Read More
Press Release
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
Read More
Press Release
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Read MorePress Release
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
Read More
External News
Benaroya Research Institute awarded $5.8M from NIH for immunology-related COVID research
Read more ➡Press Release
Dr. Oliver Harrison Awarded First NOSTER Science Microbiome Prize for Winning Essay on T Cells and Tissue Repair
Read More
News
Dr. Harrison Awarded First NOSTER Science Microbiome Prize
Read More
External News
Benaroya Research Institute at Virginia Mason is a leader in finding cure to autoimmune diseases
Watch video ➡
External News
Engineered T cells for type 1 diabetes move closer to clinic
Read more ➡
External News
